Search - tctmd.com

Displaying 1 - 20 of 42

Sort: Relevancy | Date

Presentation TCT 2025

Interventional Considerations

Presenter: Philipp Lurz

October 26, 2025

News Daily News

Intermediate Disease May Be the ‘Sweet Spot’ for T-TEER Survival Benefit

Yael L. Maxwell

February 12, 2025

Presentation THT 2025

Insights Into Hemodynamic Mechanisms of HFpEF From Advanced Invasive Hemodynamic Measurements

Presenter: Philipp Lurz

February 11, 2025

News Conference News NY Valves 2024

Transcatheter Edge-to-Edge Repair Shows Benefit in Moderate MR

Michael O'Riordan

June 10, 2024

Presentation NY Valves 2024

The Compelling Case for Transcatheter Tricuspid Therapies

Presenter: Philipp Lurz

June 07, 2024

Presentation NY Valves 2024

The Importance of Baseline Hemodynamics and Tricuspid Anatomy

Presenter: Philipp Lurz

June 07, 2024

Presentation NY Valves 2024

Heterotopic TTVR in Patients With Severe TR: First-in-Human Experience With the Trillium Device

Presenter: Philipp Lurz

June 06, 2024

Presentation NY Valves 2024

Keynote Lecture: Impact of TTVR on Hemodynamics and Ventricular Performance: Are New Generation Technologies Addressing the Physiologic Needs?

Presenter: Philipp Lurz

June 06, 2024

Presentation TCT 2023

A Novel Heterotopic Tricuspid Regurgitation Device for the Treatment of Tricuspid Regurgitation (Innoventric)

Presenter: Philipp Lurz

October 25, 2023

News Conference News TCT 2023

More TRILUMINATE Patients Flesh Out Tricuspid TEER’s Impact

Yael L. Maxwell

October 24, 2023

Presentation TVT 2023

SPOTLIGHT LECTURE: Case-Based Experiences: When and How To Use PV-Loops in the Cath Lab

Presenter: Philipp Lurz

June 08, 2023

Presentation TVT 2023

T-TEER Device Strategies: Multiple Leaflets

Presenter: Philipp Lurz

June 08, 2023

Presentation TVT 2023

M-TEER in Atrial Functional MR in HFpEF Patients

Presenter: Philipp Lurz

June 08, 2023

Presentation TVT 2023

SPOTLIGHT LECTURE: TEER in Secondary MR- Clinical Evidence, Patient Selection, and Controversies

Presenter: Philipp Lurz

June 08, 2023

Presentation THT 2023

New Insights Into the Pathophysiology of HFpEF

Presenter: Philipp Lurz

March 20, 2023

Presentation TVT 2022

Bringing Physiology to the Bedside: Evaluating Right Ventricular and Left Ventricular Function and Right Ventricular-Pulmonary Arterial Coupling in the Patient With Significant Tricuspid Regurgitation

Presenter: Philipp Lurz

June 10, 2022

Presentation TVT 2022

Tips and Tricks to Improve Leaflet Coaptation and Imaging During Tricuspid-TEER

Presenter: Philipp Lurz

June 10, 2022

News Conference News EuroPCR 2022

TriCLASP: Tricuspid Repair With Pascal Safe, Effective at 30 days

Yael L. Maxwell

May 19, 2022

News Conference News THT 2022

REDUCE LAP-HF II: Atrial Shunt Device Comes Up Short in HFpEF

Shelley Wood

February 01, 2022

News Conference News PCR London Valves 2021

Promising Early Results for TriClip in Tricuspid Regurgitation: bRIGHT Registry

Shelley Wood

November 24, 2021

Advertisement

Interventional Considerations

Intermediate Disease May Be the ‘Sweet Spot’ for T-TEER Survival Benefit

Insights Into Hemodynamic Mechanisms of HFpEF From Advanced Invasive Hemodynamic Measurements

Transcatheter Edge-to-Edge Repair Shows Benefit in Moderate MR

The Compelling Case for Transcatheter Tricuspid Therapies

The Importance of Baseline Hemodynamics and Tricuspid Anatomy

Heterotopic TTVR in Patients With Severe TR: First-in-Human Experience With the Trillium Device

Keynote Lecture: Impact of TTVR on Hemodynamics and Ventricular Performance: Are New Generation Technologies Addressing the Physiologic Needs?

A Novel Heterotopic Tricuspid Regurgitation Device for the Treatment of Tricuspid Regurgitation (Innoventric)

More TRILUMINATE Patients Flesh Out Tricuspid TEER’s Impact

SPOTLIGHT LECTURE: Case-Based Experiences: When and How To Use PV-Loops in the Cath Lab

T-TEER Device Strategies: Multiple Leaflets

M-TEER in Atrial Functional MR in HFpEF Patients

SPOTLIGHT LECTURE: TEER in Secondary MR- Clinical Evidence, Patient Selection, and Controversies

New Insights Into the Pathophysiology of HFpEF

Bringing Physiology to the Bedside: Evaluating Right Ventricular and Left Ventricular Function and Right Ventricular-Pulmonary Arterial Coupling in the Patient With Significant Tricuspid Regurgitation

Tips and Tricks to Improve Leaflet Coaptation and Imaging During Tricuspid-TEER

TriCLASP: Tricuspid Repair With Pascal Safe, Effective at 30 days

REDUCE LAP-HF II: Atrial Shunt Device Comes Up Short in HFpEF

Promising Early Results for TriClip in Tricuspid Regurgitation: bRIGHT Registry

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content